COVID-19 IgM/IgG Lateral Flow Assay
Intshayelelo yeMveliso
I-Virusee® COVID-19 IgM/IgG Lateral Flow Assay luvavanyo lokuqukuqela olusecaleni olusetyenziselwa ukufunyaniswa komgangatho we-in vitro yenoveli coronavirus (SARS-CoV-2) IgM / IgG ye-antibodies kwigazi lomntu lilonke, iplasma, kunye neesampulu zeserum.
Inoveli coronavirus yintsholongwane enemisonto enye ye-RNA.Ngokungafaniyo nayo nayiphi na i-coronavirus eyaziwayo, abantu abasesichengeni seNovel Coronavirus bahlala bechaphazeleka, kwaye isoyikiso kubantu abadala okanye abantu abanezifo ezisisiseko.Izilwa-buhlungu ze-IgM/IgG ezilungileyo luphawu olubalulekileyo losulelo lwe-coronavirus.Ukufunyaniswa kwee-antibodies ezikhethekileyo ze-coronavirus kuya kunceda ukuxilongwa kweklinikhi.
Iimpawu
| Igama | COVID-19 IgM/IgG Lateral Flow Assay |
| Indlela | I-Lateral Flow Assay |
| Uhlobo lwesampuli | Igazi, i-plasma, i-serum |
| Inkcazo | Iimvavanyo ezingama-20/ikhithi |
| Ixesha lokubona | 10 imiz |
| Izinto zokubhaqa | I-COVID-19 |
| Uzinzo | Ikhithi izinzile unyaka omnye kwi-2-30 ° C |
Inzuzo
- Ngokukhawuleza
Fumana iziphumo ngaphakathi kwe-10 min - Elula
Iziphumo zokufunda ezibonwayo, kulula ukutolika
Inkqubo elula, ngaphandle komsebenzi onzima
- Ukonga iindleko
Imveliso inokuthuthwa kwaye igcinwe kwiqondo lokushisa, ukunciphisa iindleko - Umngcipheko ophantsi
Ukuvavanya isampuli yegazi, ukunciphisa umngcipheko wenkqubo yesampuli - Ifanelekile ukujongwa kwisiza, ecaleni kwebhedi, isigulane sangaphandle
Imvelaphi kunye nomgaqo
Inoveli coronavirus, i-acute acute respiratory syndrome (SARS-CoV)-2, ichongiwe njengonobangela wesifo se-coronavirus ngo-2019 (COVID-19).Esi sifo sibizwa ngokuba yimeko engxamisekileyo yezempilo yoluntu exhalabisayo yiWorld Health Organisation (WHO).
I-COVID-19 ijolise kwiinkqubo zokuphefumla eziphezulu nezisezantsi kwaye ibangela iimpawu ezinjengomkhuhlane kubantu abaninzi abosulelekileyo.Nangona uninzi lwabaguli be-COVID-19 bafumana iimpawu ezibuthathaka kuphela, ezinye izigulana zineempawu ezinzima ezikhokelela kumonakalo omkhulu wemiphunga.Iinketho zonyango lwe-COVID-19 zilinganiselwe kwaye izinga lokusweleka ngokukrwada liqikelelwa yi-WHO limalunga ne-2.9%.Nangona iyeza lokuthintela i-COVID-19 linokufumaneka ekugqibeleni, ngaphandle kokuba ukhuselo lomhlambi olwaneleyo luphunyeziwe, i-COVID-19 inokubangela ukugula okubalulekileyo kunye nokufa kwiminyaka ezayo.
Emva kokubandezeleka kusulelo, kuqhelekile ukuphuhlisa impendulo ye-antibody ngokuchasene ne-pathogen ethile.Kwangoko emva kosulelo (ngokuqhelekileyo emva kweveki yokuqala), iklasi ye-antibodies eyaziwa ngokuba yi-immunoglobulin M (IgM) ikhula, nangona ezi zingaqhelekanga zihlala ixesha elide.Kamva, emva kweeveki ezi-2-4 zokuqala emva kosulelo, i-IgG, i-antibody eyomelele ngakumbi, iyaveliswa.
Uphononongo lufumanise ukuba izilwa-buhlungu ezijoliswe kwi-RBD ziziphawuli ezibalaseleyo zosulelo lwangaphambili kunye nolwakutshanje, ukuba imilinganiselo ye-isotype eyahlukileyo inokunceda ukwahlula phakathi kosulelo lwamva nje nolwakudala.Ukufunyaniswa kwe-IgM kunye ne-IgG antibodies ngokuchasene ne-SARS-CoV-2 inokubaluleka okunokubakho ekuvavanyeni ubukhali kunye noqikelelo lwe-COVID-19, kunye nokwandisa ukuchaneka kovavanyo lwe-asidi yenyukliya.
Ukufunyanwa kwe-SARS-CoV-2 IgM kunye ne-IgG kubaluleke kakhulu ukumisela ikhondo le-COVID-19.Ukufunyaniswa kwe-Nucleic acid kudityaniswe ne-serum antibody ye-SARS-CoV-2 inokuba sesona salathisi selabhoratri sokuxilongwa kosulelo lwe-SARS-CoV-2 kunye nebinzana kunye nokuxela kwangaphambili kwe-COVID-19.
Inkqubo yovavanyo
Ulwazi lweodolo
| Umzekelo | Inkcazo | Ikhowudi yemveliso |
| VMGLFA-01 | 20 uvavanyo/ikhithi, ifomathi yekhasethi | I-CoVMGLFA-01 |
